Source: Eur Respir J 2003; 21: 192-194
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Roeleveld R.J., Vonk Noordegraaf A., van der Bij W., Postmus P.E., Boonstra A.. Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung. Eur Respir J 2003; 21: 192-194

Member's Comments

No comment yet.

Related content which might interest you: Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease Source: Eur Respir J 2009; 34: 1348-1356 Year: 2009 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension Source: Eur Respir J 2004; 24 : 703-707 Year: 2004 Inhaled treprostinil therapy in patients with pulmonary hypertension and parenchymal lung disease Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Lung transplantation for pulmonary hypertension Source: Eur Respir Mon 2012; 57: 247-255 Year: 2012 Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation Source: Virtual Congress 2021 – All about pulmonary arterial hypertension Year: 2021 Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 23: 595-600 Year: 2004 Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Source: Eur Respir J 2007; 30: 715-721 Year: 2007 Impact of pulmonary hypertension after lung transplantation on functional outcome Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 The management of patients awaiting lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=16 Year: 2003 Lung transplantation for pulmonary arterial hypertension Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Prognosis in patients with primary pulmonary hypertension awaiting lung transplantion Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil Source: Eur Respir J 2006; 28: 1195-1203 Year: 2006 Inhaled iloprost for patients with pulmonary arterial hypertension and right heart failure Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension Source: Eur Respir J 2011; 37: 472 Year: 2011 Treatment of pulmonary hypertension in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313 Year: 2006 Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT) Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004 Long-term treatment of pulmonary hypertension with aerosolized iloprost Source: Eur Respir J 2001; 17: 8-13 Year: 2001 New issues in lung transplantation for pulmonary hypertension Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020